跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PD-1 agonists
首页
药物
PD-1 agonists
PD-1 agonists
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Antibodies against PD-1
US 7488802 B2
申请人: WYETH CORP
优先权: 2002
CN
US
9 件公开
DRUG DELIVERY COMPOSITIONS AND USES THEREOF
EP 4559479 A3
申请人: DANA FARBER CANCER INST INC
优先权: 2016
CN
EP
US
6 件公开
COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF CANCER
EP 3375791 A1
申请人: MEMORIAL SLOAN KETTERING CANCER CENTER
优先权: 2009
EP
US
5 件公开
COMPOSITIONS AND METHODS FOR CANCER TREATMENT
EP 3768236 A1
申请人: DANA FARBER CANCER INST INC
优先权: 2018
CN
EP
US
WO
4 件公开
METHOD OF TREATING PSMA-EXPRESSING CANCERS
EP 4107279 A4
申请人: ENDOCYTE INC
优先权: 2020
EP
US
WO
4 件公开
PD-1 specific antibodies and uses thereof
US 8927697 B2
申请人: DAVIS SIMON
优先权: 2009
US
4 件公开
US 9181342 B2
申请人: DAVIS SIMON
优先权: 2009
US
2 件公开
METHODS FOR TREATING CANCER WITH COMPOSITIONS COMPRISING AMLEXANOX AND IMMUNE MODULATORS
EP 3641752 A4
申请人: MOONSHOT PHARMA LLC
优先权: 2017
EP
US
WO
3 件公开
COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROLOGICAL DISORDERS
EP 4531925 A4
申请人: D&D PHARMATECH INC
优先权: 2022
EP
US
WO
3 件公开
GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST VARIANTS AND METHODS THEREOF
EP 4705331 A1
申请人: NEURALY INC
优先权: 2023
CN
EP
WO
3 件公开
CANCER IMMUNOTHERAPY
US 2014341978 A1
申请人: UNIV JOHNS HOPKINS
优先权: 2012
CN
US
3 件公开
第 1 / 3 页
上一页
下一页
药物
反馈